Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study

PURPOSE: In this multicenter study, we evaluated the cumulative burden of morbidity (CBM) among > 1,200 testicular cancer survivors and applied factor analysis to determine the co-occurrence of adverse health outcomes (AHOs). PATIENTS AND METHODS: Participants were ≤ 55 years of age at diagnosis,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Kerns, Sarah L., Fung, Chunkit, Monahan, Patrick O., Ardeshir-Rouhani-Fard, Shirin, Abu Zaid, Mohammad I., Williams, AnnaLynn M., Stump, Timothy E., Sesso, Howard D., Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Beard, Clair, Huddart, Robert A., Kim, Jeri, Kollmannsberger, Christian, Sahasrabudhe, Deepak M., Cook, Ryan, Fossa, Sophie D., Einhorn, Lawrence H., Travis, Lois B.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959198/
https://ncbi.nlm.nih.gov/pubmed/29617189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.77.0735
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares